Valuation BOIRON

Stocks

Market Closed - Euronext Paris 11:55:00 2026-10-23 EDT			5-day change	1st Jan Change
17.90 ^EUR	-0.56%		-3.76%	-40.92%

09-17	Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-22	Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	724	626.3	880.6	698.3	465.3	526.1
Change	-	-13.49%	40.6%	-20.7%	-33.37%	13.06%
Enterprise Value (EV) ¹	501.7	404.4	651.8	638	415.6	478.2
Change	-	-19.4%	61.18%	-2.12%	-34.86%	15.08%
P/E	27.6x	21.9x	19.7x	19.5x	41x	16.1x
PBR	1.42x	1.18x	1.58x	1.77x	1.23x	1.34x
PEG	-	2.46x	0.3x	-1x	-0.6x	0x
Capitalization / Revenue	1.41x	1.38x	1.65x	1.42x	0.95x	1.05x
EV / Revenue	0.98x	0.89x	1.22x	1.29x	0.85x	0.95x
EV / EBITDA	4.87x	5.76x	7.84x	9.75x	6.84x	6.92x
EV / EBIT	6.25x	8.26x	10.1x	14x	9.69x	9.27x
EV / FCF	5.11x	31.5x	17.1x	22.3x	16.9x	9.01x
FCF Yield	19.6%	3.17%	5.84%	4.47%	5.92%	11.1%
Dividend per Share ²	0.95	0.95	1.1	1.35	1.2	1.35
Rate of return	2.3%	2.66%	2.17%	3.36%	4.48%	4.46%
EPS ²	1.497	1.63	2.569	2.064	0.6529	1.88
Distribution rate	63.5%	58.3%	42.8%	65.4%	184%	71.8%
Net sales ¹	513.6	455.2	534.2	493.2	487.6	501.1
EBITDA ¹	103	70.24	83.11	65.44	60.78	69.15
EBIT ¹	80.27	48.96	64.54	45.68	42.88	51.58
Net income ¹	26.21	28.56	44.67	35.83	11.34	32.64
Net Debt ¹	-222.3	-221.9	-228.8	-60.34	-49.74	-47.86
Reference price ²	41.35	35.75	50.70	40.22	26.80	30.30
Nbr of stocks (in thousands)	17,508	17,519	17,368	17,362	17,362	17,362
Announcement Date	4/9/21	4/14/22	5/23/23	4/25/24	4/22/25	4/22/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BOIRON	-	-	-	-	348M
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.5x	18.29x	2.02%	636B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.67x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.46x	7.04x	18.70x	2.12%	400.47B
Weighted average by Cap.	35.14x	8.29x	20.39x	1.8%